白芍总苷胶囊联合雷公藤多苷片治疗类风湿性关节炎临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R593.22

基金项目:


Clinical Study on Total Glucosides of Paeony Capsules Combined with Tripterygium Wilfordii Glycosides Tablets for Rheumatoid Arthritis
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察白芍总苷胶囊联合雷公藤多苷片治疗类风湿性关节炎(RA) 的临床疗效。方法:选取76 例RA 患者,按随机数字表法分为对照组和研究组各38 例。所有患者均给予甲氨蝶呤片、硫酸羟氯喹片等常规治疗,对照组加用雷公藤多苷片治疗,研究组在对照组基础上联合白芍总苷胶囊治疗。2 组疗程均为8周。观察比较2 组临床总有效率,以及治疗前后关节症状、健康评估问卷(HAQ) 评分、抗环瓜氨酸肽(CCP) 抗体阳性率、类风湿因子(RF) 阳性率的变化。结果:研究组总有效率为94.7%,对照组为76.3%,2 组比较,差异有统计学意义(P<0.05)。治疗前,2 组关节症状压痛指数、功能障碍指数、晨僵时间、肿胀指数、疼痛指数比较,差异无统计学意义(P>0.05);治疗后,2 组上述各项指标均较治疗前显著降低(P<0.05),且研究组上述各项指标均低于对照组(P<0.05)。治疗前,2 组HAQ 评分比较,差异无统计学意义(P>0.05);治疗后,2 组HAQ 评分较治疗前显著降低(P<0.05),且研究组HAQ 评分低于对照组(P<0.05)。治疗前,2 组抗CCP 抗体、RF 阳性率比较,差异无统计学意义(P>0.05);治疗后,2 组抗CCP 抗体、RF 阳性率均较治疗前降低(P<0.05),且研究组抗CCP 抗体、RF 阳性率均低于对照组(P<0.05)。结论:白芍总苷胶囊联合雷公藤多苷片治疗RA 患者,可更好地改善其症状体征、缓解疼痛、提高有效率及生活质量,降低RF 阳性率及抗CCP 抗体阳性率。

    Abstract:

    Abstract: Objective: To observe the clinical effect of the therapy of total glucosides of paeony capsules combined with tripterygium wilfordii glycosides tablets on rheumatoid arthritis(RA). Methods: A total of 76 RA patients were randomly divided into the control group and the study group,with 38 in each group. All patients received methotrexate tablets, hydroxychloroquine sulfate tablets and other conventional treatment; the control group was additionally treated with tripterygium wilfordii glycosides tablets, and the study group was additionally treated with total glucosides of paeony capsules combined with tripterygium wilfordii glycosides tablets based on the treatment of the control group. Both groups were treated for eight weeks. The clinical effects in the two groups after treatment were observed,and the joint symptoms,the score of Health Assessment Questionnaire(HAQ),the positive rate of anti-cyclic citrulline peptide(CCP) antibody, and the positive rate of rheumatoid factor(RF) before and after treatment were observed and compared. Results:The total effective rate was 94.7% in the study group and 76.3% in the control group, the difference being significant(P<0.05). Before treatment, there was no significant difference being found in the comparison of the levels of joint symptoms, including tenderness, dysfunction,morning stiffness,swelling and pain between the two groups(P>0.05). After treatment,the above indexes in the two groups were significantly lower than those before treatment(P<0.05), and the above indexes in the study group were lower than those in the control group(P<0.05). Before treatment, there was no significant difference being found in the comparison of the HAQ scores between the two groups(P>0.05). After treatment, the HAQ scores in both groups were significantly decreased when compared with those before treatment(P<0.05), and the HAQ score in the study group was lower than that in the control group(P<0.05). Before treatment,there was no significant difference being found in the comparison of the positive rates of anti- CCP antibody and RF between the two groups(P>0.05). After treatment, the positive rates of anti- CCP antibody and RF in both groups were significantly decreased when compared with those before treatment(P<0.05),and the positive rates of anti-CCP antibody and RF in the study group were lower than those in the control group(P<0.05). Conclusion:The therapy of total glucosides of paeony capsules combined with tripterygium wilfordii glycosides tablets for RA,can improve the clinical total effective rate and quality of life,improve the joint symptoms of patients,and reduce the positive rate of RF and anti-CCP antibody.

    参考文献
    相似文献
    引证文献
引用本文

马丽丽,周攀,陈宁,潘林锋.白芍总苷胶囊联合雷公藤多苷片治疗类风湿性关节炎临床研究[J].新中医,2022,54(18):74-78

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-09-28
  • 出版日期:
文章二维码